Zdravniški Vestnik (May 2015)
Efficacy and patient satisfaction with Essure hysteroscopic sterilisation
Abstract
BACKGROUND: Essure is a permanent transcervical sterilisationprocedure. Three months after the procedure a confirmation test is performed to evaluate tubal occlusion or microinsert location. During this period the tubal lumen is occluded by benign tissue ingrowth stimulated by the microinsert. Since 2007, 169 procedures have been performed at University Medical Centre Maribor. The purpose of our study was to evaluate the efficacy, satisfaction, and complications of the procedure.METHODS: Thirty-eight consecutive patients were included in prospective study. All procedures were performed between August 2012 and March 2013 by the same experienced hysteroscopist in an outpatient setting. Transvaginal 2D ultrasound was performed 3 months after the procedure to asses the position of microinserts. Hysterosalpingo foam sonography (HyFoSy) was performed in 5 cases and hysterosalpingography (HSG) was performed once in a total of 6 cases with indeterminate position of microinserts.RESULTS: Thirty-eight patients with 75 Fallopian tubes were included. Essure microinsert was successfully placed in 73 of 75 Fallopian tubes in 37 patients (97,3%). Transvaginal ultrasound demonstrated a correct placement of 67 microinserts (67/73, 91,8%). Tubal occlusion was confirmed in all 6 cases with indeterminate position of microinserts. The overall patient satisfactory rate was 9,92 on a scale from 0 to 10.CONSCLUSION: Essure is a method for permanent female contraception that has a very high rate of success and patient satisfaction, a low rate of complications and is well tolerated. In cases of indeterminate position of microinserts on transvaginal ultrasound, HyFoSy could be an alternative to HSG.
